Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

"Very high" levels of the virus were detected by the CDC in New Mexico, with "high" levels in Oregon, Arkansas, and Maine.

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

The second booster was recommended to address the omicron variant XEC rising as a fast-spreading variant slated to take over ...

Q3 2024 PEMGARDA™ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with $106.9 million in cash and cash equivalentsTargets ...

The new Covid variant, XEC, has been taking hold across Britain in the past few weeks. If you want to avoid catching it – or a whole host of other winter nasties – it’s time to start implementing ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

People up and down the UK have complained of suffering with 'the worst cold ever' as they share their best tips on how to ...

Invivyd reports clinical efficacy data from CANOPY phase 3 trial of pemivibart: Waltham, Massachusetts Friday, November 15, 2024, 18:00 Hrs [IST] Invivyd, Inc, a biopharmaceutical ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

The monkeypox is caused by a virus transmitted to humans by infected animals and it can also be passed from human to human ...